Form EFFECT Akari Therapeutics Plc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 15, 2026 |
| Accession Number: | 0001493152-26-016154 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Three XPO Drivers Earn Top Awards at 2026 National Truck Driving Championships
- Trump Media Rethinks Bitcoin After a $200M Setback as Avalanche Surges and Apeing Whitelist Emerges in the Best Crypto Presale Race
- MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Turns to AI to Advance Precision Oncology
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
